Artigos de revistas sobre o tema "Pancancer"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Pancancer".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Wong, Chi Chun, e Jun Yu. "Mapping the pancancer metastasis tumor microbiome". Cell 187, n.º 9 (abril de 2024): 2126–28. http://dx.doi.org/10.1016/j.cell.2024.03.040.
Texto completo da fonteKappmeier, Claudia, Sherina Edward, Corinna Hochstein, Ellen Inga Bruske, Francesca Di Pasquale e Ronny Kellner. "Abstract 1470: Advancing cancer research: A novel PanCancer digital PCR tool for simultaneous detection of multiple hallmark mutations in BRAF and EGFR". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 1470. http://dx.doi.org/10.1158/1538-7445.am2024-1470.
Texto completo da fonteLi, Fei, Jing Chen, Xiaoyan Zhang, Dongxiao Yang, Liang Xia, Dazhong Wang, Kai Jin et al. "Characterization of MET exon 14 skipping in pancancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e20530-e20530. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e20530.
Texto completo da fonteCheerla, Anika, e Olivier Gevaert. "Deep learning with multimodal representation for pancancer prognosis prediction". Bioinformatics 35, n.º 14 (julho de 2019): i446—i454. http://dx.doi.org/10.1093/bioinformatics/btz342.
Texto completo da fonteLiu, Kui, Jing Ma, Jiao Ao, Lili Mu, Yixian Wang, Yue Qian, Jin Xue e Wei Zhang. "The Oncogenic Role and Immune Infiltration for CARM1 Identified by Pancancer Analysis". Journal of Oncology 2021 (27 de outubro de 2021): 1–15. http://dx.doi.org/10.1155/2021/2986444.
Texto completo da fonteJiang, Aimin, Ye Zhou, Wenliang Gong, Xin Pan, Xinxin Gan, Zhenjie Wu, Bing Liu, Le Qu e Linhui Wang. "CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types". Oxidative Medicine and Cellular Longevity 2022 (31 de março de 2022): 1–35. http://dx.doi.org/10.1155/2022/5910575.
Texto completo da fonteKarpova, Alla, Nadezhda V. Terekhanova, Siqi Chen, Reyka G. Jayasinghe, Andrew Houston, Wagma Caravan, Ryan C. Fields e Li Ding. "Abstract 2627: PanCancer epigenetic regulators of lymphocyte activation states". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 2627. http://dx.doi.org/10.1158/1538-7445.am2024-2627.
Texto completo da fonteJi, Haizhou, Mi Ren, Tongyu Liu e Yang Sun. "Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment". Disease Markers 2021 (19 de novembro de 2021): 1–21. http://dx.doi.org/10.1155/2021/5350232.
Texto completo da fonteCooper, Lee AD, Elizabeth G. Demicco, Joel H. Saltz, Reid T. Powell, Arvind Rao e Alexander J. Lazar. "PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective". Journal of Pathology 244, n.º 5 (22 de fevereiro de 2018): 512–24. http://dx.doi.org/10.1002/path.5028.
Texto completo da fonteNorton, John T., Callie B. Pollock, Chen Wang, Julian C. Schink, J. Julie Kim e Sui Huang. "Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy". Cancer 113, n.º 4 (15 de agosto de 2008): 861–69. http://dx.doi.org/10.1002/cncr.23632.
Texto completo da fonteChen, Hao, Fan Xu, Anqi Qin, Shuai Guo, Ge Zhang, Bo Yu e Quanhui Zheng. "A pancancer analysis of histone deacetylase 3 in human tumors". Translational Cancer Research 13, n.º 1 (janeiro de 2024): 65–80. http://dx.doi.org/10.21037/tcr-23-1228.
Texto completo da fonteYu, Xiaoqing, Song Li, Ling Cen e Xuefeng Wang. "Abstract 3557: A pancancer gamma delta T cell repertoire atlas". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 3557. http://dx.doi.org/10.1158/1538-7445.am2024-3557.
Texto completo da fonteWu, Yunhui, Jingying Zhang, Can Hou, Hongyu Wang, Min Zhu e Xin Yao. "A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors". Journal of Oncology 2022 (14 de junho de 2022): 1–15. http://dx.doi.org/10.1155/2022/6725570.
Texto completo da fontePeng, Ge, Saya Tsukamoto, Ko Okumura, Hideoki Ogawa, Shigaku Ikeda e François Niyonsaba. "A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors". Biology 11, n.º 2 (11 de fevereiro de 2022): 284. http://dx.doi.org/10.3390/biology11020284.
Texto completo da fonteAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang et al. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Texto completo da fonteAharonov, Ranit, Gal Dinstag, Eldad Shulman, Efrat Elis, Doreen Ben-Zvi, Omer Tirosh, Danh-Tai Hoang et al. "ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e13556-e13556. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13556.
Texto completo da fonteSwami, Nishwant, Edward Christopher Dee, Brandon A. Mahal, Fumiko Chino e Narjust Duma. "Financial toxicity in Hispanic cancer survivors: A nationally representative pancancer analysis." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 6528. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.6528.
Texto completo da fonteCui, Jing, Yongjie Tian, Tianhang Liu, Xueyan Lin, Lanyu Li, Zhonghui Li e Liang Shen. "Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy". Disease Markers 2022 (9 de setembro de 2022): 1–18. http://dx.doi.org/10.1155/2022/5447017.
Texto completo da fonteWu, Changwu, Yingjuan Duan, Siming Gong, Sonja Kallendrusch, Nikolas Schopow e Georg Osterhoff. "Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)". International Journal of Molecular Sciences 22, n.º 14 (9 de julho de 2021): 7374. http://dx.doi.org/10.3390/ijms22147374.
Texto completo da fonteYang, Jing, Xiaojing Liu, Yueqin Shao, Hong Zhou, Lijun Pang e Wei Zhu. "Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis". Computational and Mathematical Methods in Medicine 2022 (8 de dezembro de 2022): 1–19. http://dx.doi.org/10.1155/2022/3764914.
Texto completo da fonteFox, Eleonore, Guillaume Appe, Abdelkader Behdenna, Lea Meunier, Akpeli Nordor, Solene Weill e Camille Marijon. "Abstract 1915: A scalable pancancer antigen target discovery platform for precision oncology". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 1915. http://dx.doi.org/10.1158/1538-7445.am2024-1915.
Texto completo da fonteYe, Tao, Lan-lan Li, Xue-mei Peng e Qin Li. "CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis". Disease Markers 2021 (29 de dezembro de 2021): 1–8. http://dx.doi.org/10.1155/2021/8565943.
Texto completo da fonteNguyen, Phuong Thao, Yudai Shimojukkoku, Yuka Kajiya, Yasunobu Oku, Ayami Tomishima, Kaori Shima e Tomonori Sasahira. "Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer". PLOS ONE 19, n.º 5 (31 de maio de 2024): e0300446. http://dx.doi.org/10.1371/journal.pone.0300446.
Texto completo da fonteLin, Xin, Min Xiao, Zhitao Chen, Chenchen Ding, Ting Zhang e Qiyong Li. "Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors". Journal of Oncology 2022 (23 de maio de 2022): 1–40. http://dx.doi.org/10.1155/2022/6115878.
Texto completo da fonteZhou, Yiyi, Shuangshuang Xu, Qinying Sun e Yuchao Dong. "An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer". Disease Markers 2022 (11 de outubro de 2022): 1–28. http://dx.doi.org/10.1155/2022/7899961.
Texto completo da fonteOu, Qiyun, Yunfang Yu, Haitao Zhong, Anlin Li, Yongjian Chen, HaiYu Zhou, Shaopeng Zheng, Luyu Huang e Herui Yao. "Association of immune-related adverse events with immune checkpoint inhibitor efficacy in pancancer." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): e14087-e14087. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14087.
Texto completo da fonteLiu, Ranran, Tianyu Li, Guohong Zhang, Yejuan Jia, Jingxuan Liu, Lijia Pan, Yunfeng Li e Chunsheng Jia. "Pancancer Analysis Revealed the Value of RAC2 in Immunotherapy and Cancer Stem Cell". Stem Cells International 2023 (12 de maio de 2023): 1–17. http://dx.doi.org/10.1155/2023/8485726.
Texto completo da fonteNiederhausern, Andrew, Nadia S. Bahadur, Gary Wallace, Gilan E. Saadawi e John Philip. "Abstract 4966: Machine learning and large language model approach to pancancer data elements". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 4966. http://dx.doi.org/10.1158/1538-7445.am2024-4966.
Texto completo da fonteGong, Xiaoming, Tao Chen, Cheyu Lin, Haiqin Ping, Xin Tong, Kai Zhang, Zhaojun Chen, Caiyun Cai, Zhiyan Lu e Hengning Ke. "Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening". BioMed Research International 2023 (17 de abril de 2023): 1–13. http://dx.doi.org/10.1155/2023/2501596.
Texto completo da fonteWu, Zixuan, Yanhui Jiang, Xuyan Huang, Minjie Cai, Kai Yuan, Peidong Huang e Zuhong Wang. "In the Tumor Microenvironment, ETS1 Is an Oncogenic Immune Protein: An Integrative Pancancer Analysis". Evidence-Based Complementary and Alternative Medicine 2022 (15 de abril de 2022): 1–12. http://dx.doi.org/10.1155/2022/7730433.
Texto completo da fonteYang, Ziyue, Yuanyuan Zhu, Zhenfen Li, Zhangya Pu, Ying Lin, Ying Deng, Ning Li e Fang Peng. "Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4". Computational and Mathematical Methods in Medicine 2022 (17 de dezembro de 2022): 1–24. http://dx.doi.org/10.1155/2022/2528164.
Texto completo da fonteLiu, Qiaojun, Renjian Xie e Yumei Li. "Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival". International Journal of Molecular Sciences 23, n.º 17 (25 de agosto de 2022): 9611. http://dx.doi.org/10.3390/ijms23179611.
Texto completo da fonteEl-Deiry, Wafik S., Taylor Arnoff, Ilyas Sahin, Hossein Borghaei, Vivek Subbiah, Hina Khan, Benedito A. Carneiro et al. "A pancancer analysis of impact of MDM2/MDM4 on immune checkpoint blockade (ICB)." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 2630. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2630.
Texto completo da fonteDouglass, Eugene F., Robert J. Allaway, Bence Szalai, Wenyu Wang, Tingzhong Tian, Adrià Fernández-Torras, Ron Realubit et al. "A community challenge for a pancancer drug mechanism of action inference from perturbational profile data". Cell Reports Medicine 3, n.º 1 (janeiro de 2022): 100492. http://dx.doi.org/10.1016/j.xcrm.2021.100492.
Texto completo da fonteGao, Chao, Xiangqin Fan, Yanyan Liu, Yanyan Han, Shiqi Liu, Huanrong Li, Qiaoling Zhang, Yingmei Wang e Fengxia Xue. "Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer". International Journal of General Medicine Volume 16 (dezembro de 2023): 5817–39. http://dx.doi.org/10.2147/ijgm.s438479.
Texto completo da fonteLu, Jianyun, Jasmin Sponagel, Jill Jones, Hannah Gass, Elena Nunez, Cheryl Frankfater, Sierra Williams-McLeod et al. "TMET-13. SEX DIFFERENCES IN GLUCOSE METABOLISM AND MITOCHONDRIAL FUNCTION IN GLIOBLASTOMA IMPLICATE HYPOXIA-INDUCIBLE FACTOR 1 ALPHA (HIF1A) ACTIVITY". Neuro-Oncology 24, Supplement_7 (1 de novembro de 2022): vii264. http://dx.doi.org/10.1093/neuonc/noac209.1018.
Texto completo da fonteDeng, Chao, Hang Guo, Dongliang Yan, Tao Liang, Xuxiao Ye e Zuowei Li. "Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2021 (15 de abril de 2021): 1–31. http://dx.doi.org/10.1155/2021/5546612.
Texto completo da fonteMiyashita, Hirotaka, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean Glenn et al. "Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 2555. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2555.
Texto completo da fonteNiavarani, Ahmadreza, Asieh Shahrabi Farahani, Maryam Sharafkhah e Minoo Rassoulzadegan. "Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions". Carcinogenesis 39, n.º 3 (13 de janeiro de 2018): 327–35. http://dx.doi.org/10.1093/carcin/bgy005.
Texto completo da fonteArigbede, Olumide, Sarah G. Buxbaum, Sara Falzarano e Suhn Rhie. "Abstract A078: Exploration, analysis and visualization of TCGA pancancer data in the cBioPortal: Prostate adenocarcinoma genomics". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de janeiro de 2023): A078. http://dx.doi.org/10.1158/1538-7755.disp22-a078.
Texto completo da fonteChampion, Magali, Kevin Brennan, Tom Croonenborghs, Andrew J. Gentles, Nathalie Pochet e Olivier Gevaert. "Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response". EBioMedicine 27 (janeiro de 2018): 156–66. http://dx.doi.org/10.1016/j.ebiom.2017.11.028.
Texto completo da fonteReckamp, Karen L., Jasmine A. McQuerry, Isa Mambetsariev, Rebecca Pharaon, Susan E. Yost, Jeremy Fricke, Tamara Mirzapoiazova et al. "Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations". Future Science OA 7, n.º 2 (fevereiro de 2021): FSO662. http://dx.doi.org/10.2144/fsoa-2020-0159.
Texto completo da fonteWu, Zixuan, Dongli Jiang, Xuyan Huang, Minjie Cai, Kai Yuan e Peidong Huang. "S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis". Journal of Oncology 2022 (18 de março de 2022): 1–15. http://dx.doi.org/10.1155/2022/6947652.
Texto completo da fonteWu, Yumeng, Xuming Wu, Yuanyuan Li, Wenjing Zhao, Yanping Yue, Biao Wu, Jibin Liu, Xudong Chen e Aiguo Shen. "Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer". BioMed Research International 2021 (27 de setembro de 2021): 1–16. http://dx.doi.org/10.1155/2021/8201377.
Texto completo da fonteLi, Xuanyi, Ben Ho Park, Justin M. Balko e Douglas Buckner Johnson. "Pathway enrichment analysis in tumors with high mutation burdens and interferon-γ signature expression: A pancancer analysis." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): 3138. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3138.
Texto completo da fonteXu, Yining, Xinran Cui, Liyuan Zhang, Tianyi Zhao e Yadong Wang. "Metastasis-related gene identification by compound constrained NMF and a semisupervised cluster approach using pancancer multiomics features". Computers in Biology and Medicine 151 (dezembro de 2022): 106263. http://dx.doi.org/10.1016/j.compbiomed.2022.106263.
Texto completo da fonteDeng, Hui, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen e Jianchang Shu. "Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer". Molecular and Cellular Probes 73 (fevereiro de 2024): 101948. http://dx.doi.org/10.1016/j.mcp.2023.101948.
Texto completo da fonteHuang, Juntao, Ziqian Xu, Dahua Chen, Chongchang Zhou e Yi Shen. "Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors". Medicine 102, n.º 52 (29 de dezembro de 2023): e36830. http://dx.doi.org/10.1097/md.0000000000036830.
Texto completo da fonteInternational, BioMed Research. "Retracted: Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma". BioMed Research International 2024 (20 de março de 2024): 1. http://dx.doi.org/10.1155/2024/9802197.
Texto completo da fonteLeivonen, Suvi-Katri, Judit Jørgensen, Thomas Stauffer Larsen, Annika Pasanen, Marja-Liisa Karjalainen-Lindsberg, Helle M. Toldbod, Francesco d'Amore e Sirpa Leppa. "Molecular Profiling of Aggressive Non-Hodgkin Lymphoma - Results from a Phase 1/2 Preben Study". Blood 134, Supplement_1 (13 de novembro de 2019): 5314. http://dx.doi.org/10.1182/blood-2019-129113.
Texto completo da fonte